| FEATURED
PRESENTATION |
| |
Rebecca A. Taub, M.D., Vice President, Metabolic Diseases, F. Hoffmann-La Roche, Inc. |
|
SESSIONS INCLUDE:
- Overview Session
- Technical Approaches
- Reprofiling Drugs
- Screening Against Multiple Targets (Shared
Session with Compound Profiling)
|
|
Don't Miss:
Pre-Conference Short Course
Filing a 505(B)(2) Application and Strategies for Gaining Approval
Kenneth V. Phelps, President and CEO, Camargo Pharmaceuticals Services,
LLC
|
|
